Hans-Peter Gerber

发表

VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation

Napoleone Ferrara, Thiennu H. Vu, Zena Werb, 1999, Nature Medicine.

Peripheral nerve-derived VEGF promotes arterial differentiation via neuropilin 1-mediated positive feedback

Chenghua Gu, Napoleone Ferrara, N. Ferrara, 2005, Development.

Advances in patient-derived tumor xenografts: from target identification to predicting clinical response rates in oncology.

Judy Lucas, J. Lucas, E. Rosfjord, 2014, Biochemical pharmacology.

Angiogenesis-Independent Endothelial Protection of Liver: Role of VEGFR-1

Kenneth J. Hillan, Napoleone Ferrara, K. Hillan, 2003, Science.

A general approach to site-specific antibody drug conjugates

Peter G Schultz, Ying Sun, Eric Feyfant, 2014, Proceedings of the National Academy of Sciences.

Vascular endothelial growth factor is essential for corpus luteum angiogenesis

Kenneth J. Hillan, Napoleone Ferrara, K. Hillan, 1998, Nature Medicine.

Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells.

Napoleone Ferrara, G. Camenisch, R. Scheller, 2004, Blood.

Corneal avascularity is due to soluble VEGF receptor-1

J. Martin Collinson, Eiji Sakurai, Tushar Suthar, 2006, Nature.

Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway

Vishva Dixit, Minhong Yan, Napoleone Ferrara, 1998, The Journal of Biological Chemistry.

The forming limb skeleton serves as a signaling center for limb vasculature patterning via regulation of Vegf

Napoleone Ferrara, H. Akiyama, N. Ferrara, 2009, Development.

Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis.

Nan Tang, Yan Huang, Napoleone Ferrara, 2004, Cancer cell.

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

Kenneth J. Hillan, Napoleone Ferrara, K. Hillan, 2004, Nature Reviews Drug Discovery.

Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies.

Napoleone Ferrara, N. Ferrara, H. Gerber, 2005, Cancer research.

Investigational antibody drug conjugates for solid tumors

C. J. O’Donnell, H. Gerber, P. Sapra, 2011, Expert opinion on investigational drugs.

Engineered anti-CD70 antibody-drug conjugate with increased therapeutic index

Robert Lyon, Charlotte F. McDonagh, Martha Anderson, 2008, Molecular Cancer Therapeutics.